Abstract: The present invention relates to a cosmetic composition comprising: a copolymer having a constituent unit corresponding to (A) a vinyl monomer having a carboxyl group in a structure and a constituent unit corresponding to (B) a vinyl monomer represented by the following formula (1); a cationic surfactant; a higher alcohol; and a silicone oil: CH2?C(R1)—CO—X-(Q-O)r—R2??(1) wherein R1 is a hydrogen atom or a methyl group; R2 is a hydrogen atom or an alkyl group having a carbon number of 1 to 5, each of which may have a substituent; Q is an alkylene group having a carbon number of 2 to 4, which may have a substituent; r represents an integer of 2 to 15; and X represents an oxygen atom or NH, and the number of atoms bonded linearly to each other in the structure of -(Q-O)r—R2 is 70 or less.
Abstract: Embodiments of the invention are directed to a composition having antimicrobial activity comprising particles comprising at least one inorganic copper salt; and at least one functionalizing agent in contact with the particles, the functionalizing agent stabilizing the particle in a carrier such that an antimicrobially effective amount of ions are released into the environment of a microbe. The average size of the particles ranges from about 1000 nm to about 4 nm. Preferred copper salts include copper iodide, copper bromide and copper chloride. Preferred functionalizing agents include amino acids, thiols, hydrophilic polymers emulsions of hydrophobic polymers and surfactants.
Type:
Grant
Filed:
June 20, 2012
Date of Patent:
January 5, 2016
Assignee:
AGIENIC, INC.
Inventors:
Donald R. Uhlmann, Anoop Agrawal, Juan Carlos Lopez-Tonazzi, Ryan J. Reeser
Abstract: The present invention relates to a biocompatible material and in particular to a two-phase or composite biocompatible ceramic material, wherein the first phase is a doped calcium zinc silicate and the second phase is a metal oxide. In an embodiment, the invention has been developed for use in tissue regeneration including bone tissue. In other embodiments, the invention has been developed as a coating to improve the long-term stability of prior art implantable medical devices.
Type:
Grant
Filed:
June 1, 2012
Date of Patent:
December 29, 2015
Assignee:
The University of Sydney
Inventors:
Hala Zreiqat, Seyed-Iman Roohani-Esfahani, Colin Dunstan, Jiao Jiao Li
Abstract: The present invention relates to a transdermal therapeutic system for applying the active ingredient norelgestromin onto the skin, optionally in combination with estrogens. It further relates to the use of such systems for hormonal contraception, and for hormone replacement therapy.
Abstract: Aqueous homogeneous oral care compositions including a fluoride salt and unfunctionalized ?-tricalcium phosphate, characterized in that ?-tricalcium phosphate is present in a catalytic and fluoride-stable amount relative to the fluoride salt. Such compositions are of use in combating dental caries, dental erosion and/or tooth wear.
Abstract: An osteochondral scaffold has a chondrogenic spiral scaffold in one end of an outer shell made of sintered microspheres, and an osteogenic spiral scaffold in the other end of the outer shell. Each spiral scaffold has nanofibers of a composition selected to promote attachment and proliferation of the desired types of cells. The nanofibers for the chondrogenic spiral scaffold have a different composition than the nanofibers for the osteogenic spiral scaffold. The nanofibers of each spiral scaffold are aligned to orient the attached cells so as to recreate the structure of the native tissue.
Type:
Grant
Filed:
March 14, 2013
Date of Patent:
November 10, 2015
Assignee:
THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY
Abstract: The present invention relates to improved contact lens products which not only have initial insertion comfort. The contact lens product of the invention comprises a soft hydrogel contact lens immersed and autoclaved in a packaging solution including a low molecular weight polyethylene glycol (PEG) (or glycerin) and a homopolymer or copolymer of vinylpyrrolidone. The present invention also provides methods for making contact lens products of the invention.
Type:
Grant
Filed:
February 17, 2014
Date of Patent:
October 20, 2015
Assignee:
Novartis AG
Inventors:
Kasey Jon Minick, Fiona Patricia Carney, Karen Belinda Sentell, George Edward Minno
Abstract: A body wash composition comprising a surfactant, at least about 25% water, a cyclodextrin complex comprising a perfume, wherein 80% of the plurality of perfume raw materials comprise a FDV of at least 0.69.
Type:
Grant
Filed:
May 15, 2014
Date of Patent:
October 20, 2015
Assignee:
The Procter & Gamble Company
Inventors:
Timothy Alan Scavone, Jianjun Justin Li, Marc Adam Flickinger, Jonathan Robert Cetti
Abstract: A composition and methods of its use, the composition comprising: a halogen source, urea, and an additional halogen stabilizer excluding urea, optionally an alkali in a concentration sufficient to provide said composition with a pH of greater than 10; and optionally excluding a stabilized bromine compound from said composition is disclosed. Additionally, a method for reducing biological activity in a process stream is disclosed. The method comprises: providing a composition to a process stream, wherein said composition contains: a halogen, urea, and an additional halogen stabilizer excluding urea, optionally an alkali in a concentration sufficient to provide said composition with a pH of greater than 10; and optionally excluding a stabilized bromine compound from said composition. The invention is also directed to compositions and methods of their use as effective biocidal agents for water streams.
Type:
Grant
Filed:
November 4, 2011
Date of Patent:
October 20, 2015
Assignee:
NALCO COMPANY
Inventors:
Laura E. Rice, Andrew J. Cooper, Elisa M. Luth, Wen Li Tu
Abstract: Composition in the form of an oil-in-water nanoemulsion containing one or more nonionic amphiphilic lipids, one or more volatile linear alkanes and one or more oils other than the volatile linear alkane(s).
Abstract: The invention relates to novel compositions for controlling parasites on animals, comprising an N-arylpyrazole and also a pyrethroid in a formulation comprising aliphatic cyclic carbonates and aliphatic cyclic or acyclic polyethers.
Abstract: The present invention provides a clear depot comprising at least one hydrophilic water-soluble pharmaceutically active agent selected from the group consisting of vancomycin, gentamicin, a pharmaceutically acceptable salt thereof and a mixture thereof, water, a phospholipid, an oil, optionally a pH adjusting agent, and a viscosity modifying agent selected from the group consisting of ethanol, isopropanol, and a mixture thereof, wherein the water present in the depot is no more than about 4 wt % relative to the total weight of the depot and the depot has a pH of between about 3 and about 6, method of making and administering same.
Type:
Grant
Filed:
September 23, 2011
Date of Patent:
September 15, 2015
Assignee:
Dr. Reddy's Laboratories Ltd.
Inventors:
Hailiang Chen, Andrew Xian Chen, Dushyanth Surakanti, Franklin Okumu
Abstract: A cosmetic agent particularly useful for the styling of keratin fibers such as human hair is disclosed. The cosmetic agent of the present invention contains a unique combination of specific amphoteric polymers with an amphiphilic anionic polymer that imparts optimized properties to the agent without additional active ingredients. Styling agents containing this inventive polymer combination provide a very high degree of hold and moisture resistance to keratinous fibers without compromising flexibility.
Abstract: The invention concerns a co-processed additive for a solid-dose pharmaceutical composition, the additive comprising from about 50% to 99.5% by weight of at least one pharmaceutical compression aid and from about 0.5% to 50% by weight of at least one pharmaceutical lubricant, the melting point of said compression aid(s) being higher than the melting point of said lubricant(s). The co-processed additive may be in the form of a physically bound composite whereby the lubricant is associated with the surface of the compression aid particles.
Type:
Grant
Filed:
September 24, 2010
Date of Patent:
September 1, 2015
Assignee:
ZENBURY INTERNATIONAL LIMITED
Inventors:
Michael Crowley, Amanda Gage, Jack Maegli, Timothy O'Reilly
Abstract: Composition containing, in a cosmetically acceptable medium, two or more volatile linear alkanes, and one or more nonprotein cationic polymers, with a volatile linear alkanes/polymer(s) ratio by weight of greater than or equal to 1.2. Use in the treatment of keratinous substances, preferably keratinous fibres, such as the hair.
Abstract: Aspects of the invention include sunscreen formulations that include uniform, rigid, spherical nanoporous calcium phosphate particles. Also provided are methods of making the sunscreen formulations. The sunscreen formulations find use in sunblocking applications.
Type:
Grant
Filed:
November 10, 2010
Date of Patent:
August 4, 2015
Assignee:
Laboratory Skin Care, Inc.
Inventors:
Zahra Mansouri, Rodica-Tatiana Canelide, Douglas Thomas, Tetsuro Ogawa